These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 23219440)
1. Survivin expression in breast lobular carcinoma: correlations with normal breast tissue and clinicomorphological parameters. Adamkov M; Výbohová D; Horáček J; Kovalská M; Furjelová M Acta Histochem; 2013 Jun; 115(5):412-7. PubMed ID: 23219440 [TBL] [Abstract][Full Text] [Related]
2. Correlations of survivin expression with clinicomorphological parameters and hormonal receptor status in breast ductal carcinoma. Adamkov M; Kajo K; Vybohova D; Krajcovic J; Stuller F; Rajcani J Neoplasma; 2012; 59(1):30-7. PubMed ID: 22103896 [TBL] [Abstract][Full Text] [Related]
3. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis. St Romain P; Madan R; Tawfik OW; Damjanov I; Fan F Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040 [TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 overexpression associates with favourable prognostic factors in invasive breast carcinoma. El-Hafez AA; El Aaty Shawky A; Hasan B Cancer Biomark; 2012; 12(4):149-54. PubMed ID: 23568005 [TBL] [Abstract][Full Text] [Related]
5. COX-2 expression in human breast carcinomas: correlation with clinicopathological features and prognostic molecular markers. Miglietta A; Toselli M; Ravarino N; Vencia W; Chiecchio A; Bozzo F; Motta M; Torchio B; Bocca C Expert Opin Ther Targets; 2010 Jul; 14(7):655-64. PubMed ID: 20536410 [TBL] [Abstract][Full Text] [Related]
6. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas. Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613 [TBL] [Abstract][Full Text] [Related]
7. Role of E-cadherins in development of lymphatic tumor emboli. Gupta A; Deshpande CG; Badve S Cancer; 2003 May; 97(9):2341-7. PubMed ID: 12712492 [TBL] [Abstract][Full Text] [Related]
8. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma. de Candia P; Akram M; Benezra R; Brogi E Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866 [TBL] [Abstract][Full Text] [Related]
9. Expression of survivin and clinical correlation in patients with breast cancer. Sohn DM; Kim SY; Baek MJ; Lim CW; Lee MH; Cho MS; Kim TY Biomed Pharmacother; 2006 Jul; 60(6):289-92. PubMed ID: 16876381 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between "triple-negative" and non-"triple-negative" tumors. Tawfik K; Kimler BF; Davis MK; Fan F; Tawfik O Hum Pathol; 2012 Jan; 43(1):23-30. PubMed ID: 21777944 [TBL] [Abstract][Full Text] [Related]
11. Do we need HER-2/neu testing for all patients with primary breast carcinoma? Taucher S; Rudas M; Mader RM; Gnant M; Dubsky P; Bachleitner T; Roka S; Fitzal F; Kandioler D; Sporn E; Friedl J; Mittlböck M; Jakesz R Cancer; 2003 Dec; 98(12):2547-53. PubMed ID: 14669272 [TBL] [Abstract][Full Text] [Related]
12. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival. Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124 [TBL] [Abstract][Full Text] [Related]
13. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis. D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic and prognostic evaluation of invasive breast carcinoma molecular subtypes and GATA3 expression. Demir H; Turna H; Can G; Ilvan S J BUON; 2010; 15(4):774-82. PubMed ID: 21229645 [TBL] [Abstract][Full Text] [Related]
15. Predicting axillary sentinel node status in patients with primary breast cancer. Kolarik D; Pecha V; Skovajsova M; Zahumensky J; Trnkova M; Petruzelka L; Halaska M; Sottner O; Otcenasek M; Kolarova H Neoplasma; 2013; 60(3):334-42. PubMed ID: 23374005 [TBL] [Abstract][Full Text] [Related]
16. Clinical and biological characteristics of breast cancer. Kocic B; Filipovic S; Petrovic B; Mijalkovic D; Rancic N; Poultsidi A J BUON; 2010; 15(4):660-7. PubMed ID: 21229626 [TBL] [Abstract][Full Text] [Related]
17. Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy. Mustać E; Matusan-Ilijas K; Marijić B; Smokvina M; Jonjić N Int J Surg Pathol; 2010 Feb; 18(1):36-41. PubMed ID: 19448065 [TBL] [Abstract][Full Text] [Related]
18. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA. Yie SM; Luo B; Ye NY; Xie K; Ye SR Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357 [TBL] [Abstract][Full Text] [Related]
19. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance. Rakha EA; Abd El Rehim D; Pinder SE; Lewis SA; Ellis IO Histopathology; 2005 Jun; 46(6):685-93. PubMed ID: 15910600 [TBL] [Abstract][Full Text] [Related]
20. Survivin in breast lesions: immunohistochemical analysis of 196 cases. Adamkov M; Drahošová S; Chylíková J; Výbohová D Pol J Pathol; 2017; 68(4):297-305. PubMed ID: 29517199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]